VIRMA and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myeloid leukemia, the combination of RNA-seq data and MeRIP-seq data in the m6a2target database showed that targets of KIAA1429 were mainly enriched in enzyme activity inhibition, focal adhesion, and exocytosis [25].